These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28543740)

  • 1. Global regulatory requirements for mutagenicity assessment in the registration of industrial chemicals.
    Ji Z; Ball NS; LeBaron MJ
    Environ Mol Mutagen; 2017 Jun; 58(5):345-353. PubMed ID: 28543740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of genetic toxicity data in GHS mutagenicity classification and labeling of substances.
    Ball NS; Hollnagel HM
    Environ Mol Mutagen; 2017 Jun; 58(5):354-360. PubMed ID: 28485542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs.
    Auletta AE; Dearfield KL; Cimino MC
    Environ Mol Mutagen; 1993; 21(1):38-45; discussion 46-57. PubMed ID: 8419153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment and global regulatory requirements for genetic toxicity evaluations of medical devices.
    Przygoda RT
    Environ Mol Mutagen; 2017 Jun; 58(5):375-379. PubMed ID: 28573657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory requirements for genotoxicity assessment of plant protection product active ingredients, impurities, and metabolites.
    Booth ED; Rawlinson PJ; Maria Fagundes P; Leiner KA
    Environ Mol Mutagen; 2017 Jun; 58(5):325-344. PubMed ID: 28329407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low efficiency of short-term tests in the assessment of the potential mutagenic hazard of chemical compounds to mammals].
    Tarasov VA; Velibekov RM; Liubimova IK; Aslanian MM
    Genetika; 2001 Jul; 37(7):1008-17. PubMed ID: 11558223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment.
    Klapacz J; Gollapudi BB
    Environ Mol Mutagen; 2020 Jan; 61(1):84-93. PubMed ID: 31301246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances.
    Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P
    ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory assessment of chemicals within OECD member countries, EU and in Russia.
    Fjodorova N; Novich M; Vrachko M; Kharchevnikova N; Zholdakova Z; Sinitsyna O; Benfenati E
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(1):40-88. PubMed ID: 18322867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotoxicity testing approaches for the safety assessment of substances used in food contact materials prior to their authorization in the European Union.
    Bolognesi C; Castoldi AF; Crebelli R; Barthélémy E; Maurici D; Wölfle D; Volk K; Castle L
    Environ Mol Mutagen; 2017 Jun; 58(5):361-374. PubMed ID: 28556235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a next generation framework for assessment of genomic damage: A case study using the industrial chemical benzene.
    Luijten M; Ball NS; Dearfield KL; Gollapudi BB; Johnson GE; Madia F; Peel L; Pfuhler S; Settivari RS; Ter Burg W; White PA; van Benthem J
    Environ Mol Mutagen; 2020 Jan; 61(1):94-113. PubMed ID: 31709603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of the mutagenicity/genotoxicity data of the cosmetic ingredients present on the Annexes of the Cosmetic EU legislation (2000-12).
    Ates G; Doktorova TY; Pauwels M; Rogiers V
    Mutagenesis; 2014 Mar; 29(2):115-21. PubMed ID: 24435663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated strategy for mutagenicity prediction applied to food contact chemicals.
    Manganelli S; Schilter B; Benfenati E; Manganaro A; Lo Piparo E
    ALTEX; 2018; 35(2):169-178. PubMed ID: 28922667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practice of expert review by read-across using QSAR Toolbox.
    Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
    Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.